相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。An amiloride derivative is active against the F1Fo-ATP synthase and cytochrome bd oxidase of Mycobacterium tuberculosis
Kiel Hards et al.
COMMUNICATIONS BIOLOGY (2022)
Dual inhibition of the terminal oxidases eradicates antibiotic-tolerant Mycobacterium tuberculosis
Bei Shi Lee et al.
EMBO MOLECULAR MEDICINE (2021)
Structure guided generation of thieno[3,2-d] pyrimidin-4-amine Mycobacterium tuberculosis bd oxidase inhibitors
Sarah M. Hopfner et al.
RSC MEDICINAL CHEMISTRY (2021)
New antituberculosis drugs targeting the respiratory chain
Qian Li et al.
CHINESE CHEMICAL LETTERS (2020)
Features of the biochemistry of Mycobacterium smegmatis, as a possible model for Mycobacterium tuberculosis
Joseph Antony Sundarsingh T et al.
Journal of Infection and Public Health (2020)
Clofazimine for the treatment of multidrug-resistant tuberculosis
C. Lange et al.
CLINICAL MICROBIOLOGY AND INFECTION (2019)
Mycolicibacterium smegmatis, Basonym Mycobacterium smegmatis, Expresses Morphological Phenotypes Much More Similar to Escherichia coli Than Mycobacterium tuberculosis in Quantitative Structome Analysis and CryoTEM Examination
Hiroyuki Yamada et al.
FRONTIERS IN MICROBIOLOGY (2018)
Exploiting the synthetic lethality between terminal respiratory oxidases to kill Mycobacterium tuberculosis and clear host infection
Nitin P. Kalia et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
Susceptibility of Mycobacterium tuberculosis Cytochrome bd Oxidase Mutants to Compounds Targeting the Terminal Respiratory Oxidase, Cytochrome c
Atica Moosa et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2017)
Respiratory Flexibility in Response to Inhibition of Cytochrome c Oxidase in Mycobacterium tuberculosis
Kriti Arora et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
Lead Optimization of a Novel Series of Imidazo[1,2-a]pyridine Amides Leading to a Clinical Candidate (Q203) as a Multi- and Extensively-Drug-Resistant Anti-tuberculosis Agent
Sunhee Kang et al.
JOURNAL OF MEDICINAL CHEMISTRY (2014)
A Mycobacterium tuberculosis Cytochrome bd Oxidase Mutant Is Hypersensitive to Bedaquiline
Michael Berney et al.
MBIO (2014)
Synthesis and biological activities of the respiratory chain inhibitor aurachin D and new ring versus chain analogues
Xu-Wen Li et al.
BEILSTEIN JOURNAL OF ORGANIC CHEMISTRY (2013)
Systematic review of clofazimine for the treatment of drug-resistant tuberculosis
M. Gopal et al.
INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE (2013)
Discovery of Q203, a potent clinical candidate for the treatment of tuberculosis
Kevin Pethe et al.
NATURE MEDICINE (2013)
Tuberculosis success
Dan Jones
NATURE REVIEWS DRUG DISCOVERY (2013)
Synthesis of aurachin D and isoprenoid analogues from the myxobacterium Stigmatella aurantiaca
Lisa Dejon et al.
TETRAHEDRON LETTERS (2013)
Randomized Pilot Trial of Eight Weeks of Bedaquiline (TMC207) Treatment for Multidrug-Resistant Tuberculosis: Long-Term Outcome, Tolerability, and Effect on Emergence of Drug Resistance
A. H. Diacon et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
Aerobic respiratory chain of Escherichia coli is not allowed to work in fully uncoupled mode
Vitaliy B. Borisov et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Cytochrome bd from Azotobacter vinelandii:: Evidence for high-affinity oxygen binding
Ilya Belevich et al.
BIOCHEMISTRY (2007)
Diarylquinolines target subunit c of mycobacterial ATP synthase
Anil Koul et al.
NATURE CHEMICAL BIOLOGY (2007)
A diarylquinoline drug active on the ATP synthase of Mycobacterium tuberculosis
K Andries et al.
SCIENCE (2005)
分享论文
